健脾祛湿方加减治疗湿热困脾型2型糖尿病合并脂肪肝临床观察  

Clinical observation on treating type 2 diabetes of the Shire Kunpi type and fatty liver with the Jianpi Qushi prescription

作　　者：周惟强[1] 

机构地区：[1]无锡市中医医院,江苏无锡214000

出　　处：《中医临床研究》2018年第29期64-66,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨湿热困脾型2型糖尿病合并脂肪肝患者采用健脾祛湿方加减治疗的临床效果。方法:选择2016年2月-2017年8月我院收治的湿热困脾型2型糖尿病合并脂肪肝患者150例,将所有患者随机分为两组,各75例。对照组予以吡格列酮治疗,观察组实施健脾祛湿方加减治疗,比较两组患者血糖、血脂及肝功能指标水平。结果:治疗后观察组患者各血糖、血脂指标水平及肝功能指标水平均低于对照组,差异有统计学意义(P <0.05)。结论:对湿热困脾型2型糖尿病合并脂肪肝患者实施健脾祛湿方加减治疗可显著降低其血糖、血脂水平,并在一定程度上改善其肝功能,有利于加快相关症状的好转。Objective:To explore clinical efficacy of the Jianpi Qushi prescription(健脾祛湿方)on type 2 diabetes of the Shire Kunpi type(湿热困脾型)and fatty liver.Methods:From February 2016 to August 2017,150 cases were divided into two groups,75 cases in each.The control group was given pioglitazone;and the observation group was given the Jianpi Qushi prescription.Results:After treatment,the blood glucose,blood lipid index and liver function index in the observation group were lower(P<0.05).Conclusion:The Jianpi Qushi prescription on type 2 diabetes of the Shire Kunpi type and fatty liver shows a significant effect,can significantly reduce the level of blood sugar and blood lipid,improve liver function,and is worthy of promotion.

关 键 词：2型糖尿病 脂肪肝 湿热困脾型 健脾祛湿 血糖、血脂水平 肝功能 

分 类 号：R587.1[医药卫生—内分泌]